T. Rowe Price Associates
AEHR icon

T. Rowe Price Associates’s Aehr Test Systems AEHR Stock Holding History

T. Rowe Price Associates’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.7M Sell
507,035
-842,316
-62% -$77M ﹤0.01% 898
2026
Q1 		$50M Buy
1,349,351
+1,314,967
+3,824% +$42.1M 0.01% 769
2025
Q4 		$695K Sell
34,384
-10,862
-24% -$263K ﹤0.01% 2249
2025
Q3 		$1.36M Buy
45,246
+1,975
+5% +$42.8K ﹤0.01% 1920
2025
Q2 		$560K Buy
43,271
+855
+2% +$8.14K ﹤0.01% 2250
2025
Q1 		$310K Buy
42,416
+17,700
+72% +$196K ﹤0.01% 2461
2024
Q4 		$412K Buy
24,716
+4,772
+24% +$63.6K ﹤0.01% 2366
2024
Q3 		$257K Buy
19,944
+276
+1% +$3.99K ﹤0.01% 2543
2024
Q2 		$220K Buy
19,668
+3,650
+23% +$42.5K ﹤0.01% 2557
2024
Q1 		$199K Buy
16,018
+961
+6% +$16K ﹤0.01% 2626
2023
Q4 		$400K Buy
15,057
+2,042
+16% +$59.6K ﹤0.01% 2269
2023
Q3 		$595K Buy
13,015
+474
+4% +$22K ﹤0.01% 2025
2023
Q2 		$518K Buy
+12,541
New +$411K ﹤0.01% 2108
2022
Q2 		– Sell
-12,300
Closed -$125K – 2958
2022
Q1 		$125K Buy
+12,300
New +$157K ﹤0.01% 2810

Other funds holding AEHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates's AEHR Position: Q2 2026 in Review

T. Rowe Price Associates reduced its Aehr Test Systems (AEHR) stake by 62% in Q2 2026, selling an estimated $77M and leaving 507,035 shares worth $48.7M. The position accounts for ﹤0.01% of the portfolio, ranked #898.

T. Rowe Price Associates first reported a position in AEHR in Q1 2022 and has held it in 14 quarters since. The position peaked at $50M in Q1 2026. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • T. Rowe Price Associates held 507,035 shares of Aehr Test Systems worth $48.7M as of Q2 2026.
  • T. Rowe Price Associates sold 842,316 Aehr Test Systems shares in Q2 2026, an estimated $77M.
  • Aehr Test Systems made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #898 holding.
  • T. Rowe Price Associates first reported a position in Aehr Test Systems in Q1 2022 and has held it in 14 quarters since.
  • T. Rowe Price Associates's Aehr Test Systems position peaked at $50M in Q1 2026.
  • 262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.